Short Interest in Atrion Co. (NASDAQ:ATRI) Decreases By 26.0%

Atrion Co. (NASDAQ:ATRI) was the recipient of a large drop in short interest in the month of July. As of July 15th, there was short interest totalling 44,500 shares, a drop of 26.0% from the June 30th total of 60,100 shares. Based on an average trading volume of 31,200 shares, the days-to-cover ratio is currently 1.4 days. Currently, 3.3% of the shares of the company are sold short.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in ATRI. BNP Paribas Financial Markets grew its position in Atrion by 3.6% during the first quarter. BNP Paribas Financial Markets now owns 723 shares of the medical instruments supplier’s stock worth $335,000 after buying an additional 25 shares in the last quarter. Copeland Capital Management LLC lifted its position in shares of Atrion by 56.4% in the 4th quarter. Copeland Capital Management LLC now owns 86 shares of the medical instruments supplier’s stock worth $33,000 after acquiring an additional 31 shares during the period. Harbor Investment Advisory LLC grew its holdings in shares of Atrion by 33.1% during the 4th quarter. Harbor Investment Advisory LLC now owns 189 shares of the medical instruments supplier’s stock worth $72,000 after purchasing an additional 47 shares in the last quarter. Quadrant Capital Group LLC bought a new stake in shares of Atrion during the fourth quarter valued at approximately $36,000. Finally, Oppenheimer Asset Management Inc. raised its stake in shares of Atrion by 12.0% in the first quarter. Oppenheimer Asset Management Inc. now owns 1,105 shares of the medical instruments supplier’s stock valued at $512,000 after purchasing an additional 118 shares in the last quarter. Institutional investors own 66.19% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com started coverage on shares of Atrion in a report on Thursday. They set a “sell” rating for the company.

Atrion Trading Up 0.1 %

NASDAQ:ATRI traded up $0.45 during mid-day trading on Monday, hitting $458.10. 25,725 shares of the company’s stock traded hands, compared to its average volume of 23,420. The firm has a market capitalization of $806.26 million, a price-to-earnings ratio of 43.05 and a beta of 0.68. The firm has a 50 day moving average of $456.19 and a two-hundred day moving average of $415.06. Atrion has a 12 month low of $274.98 and a 12 month high of $564.21.

Atrion (NASDAQ:ATRI) last posted its quarterly earnings data on Friday, May 10th. The medical instruments supplier reported $1.59 earnings per share for the quarter. The company had revenue of $47.33 million during the quarter. Atrion had a return on equity of 7.75% and a net margin of 10.60%.

Atrion Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, June 28th. Shareholders of record on Friday, June 14th were given a $2.20 dividend. The ex-dividend date was Friday, June 14th. This represents a $8.80 annualized dividend and a yield of 1.92%. Atrion’s dividend payout ratio is 82.71%.

About Atrion

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.